Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

20102,493 citationsJournal Articlegreen Open Access

Authors

Robert Timmerman · The University of Texas Southwestern Medical Center

Abstract

Patients with inoperable non-small cell lung cancer who received stereotactic body radiation therapy had a survival rate of 55.8% at 3 years, high rates of local tumor control, and moderate treatment-related morbidity.

Topics & Keywords

Lung Cancer Diagnosis and Treatment Advanced Radiotherapy Techniques Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 303, Issue 11, pp. 1070-1070

DOI: 10.1001/jama.2010.261

Field-Weighted Citation Impact: 113.37